A-T FAMILIES PROVIDING DATA TO RESEARCHERS

A year has passed since the launch of the Global A-T Family Data Platform, an effort overseen by A-T families to enable researchers and clinicians to mine large data sets and gain new insights about ataxia-telangiectasia. So far, A-T families from 19 countries have contributed health information about their children who have A-T. The platform’s … Read More

LONG TIME ADVISORS ELECTED TO THE NATIONAL ACADEMY OF SCIENCES

Two of our long time scientific advisors have been elected to the prestigious National Academy of Sciences, one of the highest honors bestowed upon research scientists. Nathaniel Heintz, PhD Nathaniel (Nat) Heintz is the James and Marilyn Simons Professor and head of the Laboratory of Molecular Biology at The Rockefeller University in New York. Dr. … Read More

FAMILIES OF ATAXIA-TELANGIECTASIA PATIENTS WORLDWIDE LAUNCH NEW DATA PLATFORM TO EMPOWER RESEARCHERS

Families will contribute their data using on-line family questionnaires, whole-genome sequencing and other approaches, serving as a model for other diseases Families around the world who have children affected by ataxia-telangiectasia (A-T) today announced the launch of the Global A-T Family Data Platform, through which health, genomic and potentially other types of data about their … Read More

ATW2015 INCLUDES SESSIONS ON NEUROGENERATION AND NON-TRADITIONAL ROLES OF THE A-T PROTEIN

Scientists and clinicians from around the world traveled to Beijing, China in October to share information at the 2015 A-T Workshop, a meeting co-sponsored by the A-T Children’s Project and held at the Capital Normal University. Beyond primarily discussing DNA repair roles of the ATM protein as in the past, this year’s meeting included sessions … Read More

RECURSION PHARMACEUTICALS ANNOUNCES FUNDING SUPPORT FOR ATAXIA-TELANGIECTASIA

Press Release from Recursion Pharmaceuticals Salt Lake City – Recursion Pharmaceuticals, an emerging biotech company today announced receipt of a research award from the A-T Children’s Project, which seeks to support research for the disease ataxia-telangiectasia. Ataxia-telangiectasia (A-T) is a rare genetic disease that attacks children, causing progressive loss of muscle control, immune system problems, … Read More

UNRAVELLING NERVE-CELL DEATH IN RARE CHILDREN’S DISEASE

From the Sanford-Burnham Medical Research Institute Press Release: Researchers discover mutations in a protein that plays a role in the body’s DNA repair system—similar to what’s observed in the rare children’s disease ataxia-telangiectasia. The discovery provides an approach to identifying therapies that will resuscitate the broken DNA repair mechanism. Newswise — LA JOLLA, Calif., March … Read More